\
&
Contact us
Starts in 1 month from now
LocationUsquare Brussels
This onsite matchmaking event organised by NEB4All - the European network of NEB NCPs – aims to help potential applicants to find partners and to build a consortium for the 2026 calls of the NEB Facility Work Programme 2026-2027.
What to expect?
Target audience: Universities, research centres, municipalities, companies (SMEs & large), civil society organisations, cultural and creative actors, and any R&D-focused stakeholders ready to co-create for the NEB initiative.
Potential applicants are invited to register on the matchmaking platform if they are interested in joining this event. To be validated and secure a spot during the onsite matchmaking, they need to comply with some quality criteria (details described on the platform).
For applicants that can’t make it to Brussels, note that the onsite event will be followed by online long-term matchmaking. They will thus be able to join the participant pool at a later stage.
This matchmaking event complements the NEB Facility Info Day that will be organised by the European Commission on 24 February 2026.
For more information about the event and registration please visit the webpage of the event.
We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).
Stay informed about what matters to you.
By signing up, you can opt in for e-mail notifications and get access to
a personalised dashboard that groups all news updates and event announcements in your domain(s).
Only for stakeholders located in Flanders
The Horizon2020 project BEAT-AF brings together 9 European renowned clinical centres in France, Belgium, Czechia, Germany and Austria. Together, the consortium strives to revolutionize Atrial Fibrillation (AF) treatment through catheter ablation and contribute to decrease the huge burden of AF in Europe. The BEAT-AF project kicked off in 2021 and will run until 2026. The department of electrophysiology of the AZ Sint-Jan Hospital in Bruges is partner in the project and has so far contributed to the pre-clinical development, the first in man studies and first registries of the revolutionary AF treatment put forward by the consortium. The first pilot studies show that the treatment is safe, effective and efficient.